Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2013-01-30

Original market date: See footnote 1

1984-12-31

Product name:

EPIPEN JR

Description:

0.15MG/0.3ML AUTO-INJECTOR

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

00578657

Product Monograph/Veterinary Labelling:

Date: 2020-04-09 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

MYLAN SPECIALTY LP
781 Chestnut Ridge Road
Morgantown
West Virginia
United States  26504-4310

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Ethical  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

12:12.12   ALPHA-AND BETA-ADRENERGIC AGONISTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

C01CA24  EPINEPHRINE

Active ingredient group (AIG) number:See footnote 5

0104871011

List of active ingredient(s)
Active ingredient(s) Strength
EPINEPHRINE 0.15 MG / 0.3 ML

Application information

Related information

Contact us

Version 3.8.0
Date modified: